Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck Ultrasound
Authors:
- Giorgio GraniGGGiorgio Grani
- Valeria RamundoVRValeria Ramundo
- Rosa FalconeRFRosa Falcone
- Livia LamartinaLLLivia Lamartina
- Marco BiffoniMBMarco Biffoni
- Laura GiacomelliLGLaura Giacomelli
- Marialuisa SponzielloMSMarialuisa Sponziello
- Antonella VerrientiAVAntonella Verrienti
- Sebastiano FilettiSFSebastiano Filetti
- Cosimo DuranteCDCosimo Durante
Open Access
- 17 June 2019
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 104 (11) , 4981-4989
Abstract
Context: Ultrasonography (US) is considered the most sensitive tool for imaging persistent or recurrent papillary thyroid cancer (PTC) in the neck. Objective: To clarify the usefulness of routine neck US in low- and intermediate-risk patients with PTC with no evidence of disease 1 year after thyroidectomy. Design: Retrospective analysis of prospectively recorded data. Setting: Academic center. Patients: Two hundred twenty-six patients with PTC with sonographically normal neck lymph nodes and unstimulated serum thyroglobulin (Tg) levels that were either undetectable (<0.20 ng/mL) or low (0.21 to 0.99 ng/mL) at the 1-year evaluation. Interventions: Yearly assessment: unstimulated serum Tg level, anti-Tg-antibody (TgAb) titer, TSH levels, and ultrasound examination of neck lymph nodes. Main Outcome Measures: Rates of ultrasonographic lymph node abnormalities at the 3-year and last follow-up visits. Results: In patients with an undetectable Tg level at the 1-year evaluation, sonographically suspicious neck lymph nodes were found in 1.2% of patients at 3 years and in 1.8% at the last visit [negative predictive values (NPVs) of 1-year Tg < 0.2 ng/mL: 98.8% (95% CI 95.8% to 99.9%) and 98.2% (95% to 99.6%), respectively]. Similar NPVs emerged for low detectable 1-year Tg levels [98.2% (90.3% to 99.9%) and 94.5% (84.9% to 98.9%) at the 3-year and last visits, respectively]. Seventy-five percent of the nodal lesions were likely false positive; none required treatment. Conclusions: Low- and intermediate-risk patients with PTC with negative ultrasound findings and unstimulated Tg levels <1 ng/mL at the 1-year evaluation can be safely followed with clinical assessments and unstimulated serum Tg determinations. Neck US might be repeated if TgAb titers rise, or unstimulated Tg levels exceed 1 ng/mL.Keywords
Funding Information
- Sapienza University of Rome (C26V16RBXB)
This publication has 30 references indexed in Scilit:
- Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the LiteratureThe Journal of Clinical Endocrinology & Metabolism, 2015
- Thyroglobulin measurement by highly sensitive assays: focus on laboratory challengesClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Update on Differentiated Thyroid Cancer StagingEndocrinology and Metabolism Clinics of North America, 2014
- Thyroglobulin in Lymph Node Fine-Needle Aspiration Washout: A Systematic Review and Meta-analysis of Diagnostic AccuracyThe Journal of Clinical Endocrinology & Metabolism, 2014
- Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablationEuropean Journal of Endocrinology, 2013
- 2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid CancerEuropean Thyroid Journal, 2013
- Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2011
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Follow-Up of Low Risk Patients with Papillary Thyroid Cancer: Role of Neck Ultrasonography in Detecting Lymph Node MetastasesThe Journal of Clinical Endocrinology & Metabolism, 2004
- Early Diagnosis by Genetic Analysis of Differentiated Thyroid Cancer Metastases in Small Lymph NodesThe Journal of Clinical Endocrinology & Metabolism, 1997